![Geoffrey Elliott](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Geoffrey Elliott
Direktor/Vorstandsmitglied bei Pharmapac Holdings Ltd.
Profil
Geoffrey Elliott currently works at Pharmapac (U.K.) Ltd., as Director from 2014 and Pharmapac Holdings Ltd., as Secretary & Director.
Aktive Positionen von Geoffrey Elliott
Unternehmen | Position | Beginn |
---|---|---|
Pharmapac Holdings Ltd.
![]() Pharmapac Holdings Ltd. Pharmaceuticals: MajorHealth Technology Pharmapac Holdings Ltd. operates as a holding British company with subsidiaries that manufacture pharmaceutical and healthcare products. The private company is based in Craigavon, UK. | Direktor/Vorstandsmitglied | - |
Pharmapac (U.K.) Ltd.
![]() Pharmapac (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Inyx, Inc., Pharmapac (U.K.) Ltd. is a British company that manufactures and distributes wholesale pharmaceutical products. The company is based in Bidston, UK. The company was founded in 1996. Pharmapac (U.K. was acquired by INYX Pharma Ltd. on November 14, 2006 for $19.83 million. | Direktor/Vorstandsmitglied | 19.12.2014 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Pharmapac Holdings Ltd.
![]() Pharmapac Holdings Ltd. Pharmaceuticals: MajorHealth Technology Pharmapac Holdings Ltd. operates as a holding British company with subsidiaries that manufacture pharmaceutical and healthcare products. The private company is based in Craigavon, UK. | Health Technology |
Pharmapac (U.K.) Ltd.
![]() Pharmapac (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Inyx, Inc., Pharmapac (U.K.) Ltd. is a British company that manufactures and distributes wholesale pharmaceutical products. The company is based in Bidston, UK. The company was founded in 1996. Pharmapac (U.K. was acquired by INYX Pharma Ltd. on November 14, 2006 for $19.83 million. | Health Technology |